{Reference Type}: Journal Article
{Title}: Retrospective Study of the Upsurge of Enterovirus D68 Clade D1 among Adults (2014-2018).
{Author}: Duval M;Mirand A;Lesens O;Bay JO;Caillaud D;Gallot D;Lautrette A;Montcouquiol S;Schmidt J;Egron C;Jugie G;Bisseux M;Archimbaud C;Lambert C;Henquell C;Bailly JL;
{Journal}: Viruses
{Volume}: 13
{Issue}: 8
{Year}: 08 2021 13
{Factor}: 5.818
{DOI}: 10.3390/v13081607
{Abstract}: Enterovirus D68 (EV-D68) has emerged as an agent of epidemic respiratory illness and acute flaccid myelitis in the paediatric population but data are lacking in adult patients. We performed a 4.5-year single-centre retrospective study of all patients who tested positive for EV-D68 and analysed full-length EV-D68 genomes of the predominant clades B3 and D1. Between 1 June 2014, and 31 December 2018, 73 of the 11,365 patients investigated for respiratory pathogens tested positive for EV-D68, of whom 20 (27%) were adults (median age 53.7 years [IQR 34.0-65.7]) and 53 (73%) were children (median age 1.9 years [IQR 0.2-4.0]). The proportion of adults increased from 12% in 2014 to 48% in 2018 (p = 0.01). All adults had an underlying comorbidity factor, including chronic lung disease in 12 (60%), diabetes mellitus in six (30%), and chronic heart disease in five (25%). Clade D1 infected a higher proportion of adults than clades B3 and B2 (p = 0.001). Clade D1 was more divergent than clade B3: 5 of 19 amino acid changes in the capsid proteins were located in putative antigenic sites. Adult patients with underlying conditions are more likely to present with severe complications associated with EV-D68, notably the emergent clade D1.